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In an effort to  elucidate the heterogeneity of schizophrenia
much research has been aimed at exploration of the relation-
ships between its various symptoms and co-morbid disorders.
It is hoped that the neurobiological implications of diagnostic
overlap may bring new insight to the pathophysiology under-
lying these disorders, and conversely offer improved treatment
options for these patients.  In particular co-morbid OCD and
schizophrenia may significantly influence the functional
outcome of patients.1 2
Previous studies have reported the prevalence of OCD in
patients with schizophrenia to be between 7.8% and 31.7%.3 7
Defining obsessions as ‘persistent unwanted ideas not related
to delusions’, Eisen et al.3 found that 7.8% of patients with
schizophrenia or schizoaffective disorder who were directly
interviewed (N = 77) (SCID Diagnostic and Statistical Manual
(DSM) III-R) met the criteria for OCD.3 Using DSM-IV8 criteria,
Bermanzohn et al.5 found that 29.7% of consecutively admitted
chronic schizophrenia patients could be diagnosed with co-
morbid OCD.   Community surveys such as the Epidemiological
Catchment Area (ECA) study9
(N = 20 861) have yielded an OCD co-occurrence rate of 23.7%,
but the measurement instrument did not include diagnostic
hierarchy rules.   In a study6 that did include diagnostic
hierarchy rules (SCID - DSM-IV), 14% of 50 first-episode
schizophrenia, schizophreniform or schizoaffective patients
met criteria for OCD.
The use of different definitions of OCD (symptoms versus
disorder) and methodologies (chart review versus direct
interview, patient versus community samples, schizophrenia
versus schizophrenia spectrum subjects, lay versus clinician
assessments, cross-sectional versus longitudinal design) has
complicated comparisons between studies and has therefore
possibly contributed to the considerable variation in prevalence
estimates.  Nevertheless, calculated co-morbidity rates support
the conclusion of many studies that co-morbidity of OCD with
schizophrenia is more than an incidental finding.10 This work
raises the question of whether shared susceptibility factors,
such as dopamine dysregulation, may in fact characterise
patients with co-morbid OCD and schizophrenia. 
To date, studies have mostly focused on Caucasian patients.
Both schizophrenia11 and OCD12 are disorders with significant
commonality across different cultures and ethnic groupings.
Nevertheless, there is some evidence of variation in the
phenomenology of schizophrenia across ethnic groups,13 and it
has also been suggested that OCD may be less common in
certain communities.14 Up to the present, however, with the
exception of Koen et al.15 who reported a low rate (1.1%) of co-
morbid OCD in first- and multi-episode male South African
patients with schizophrenia, there exists a paucity of published
data on the co-morbidity of OCD in non-Caucasian
schizophrenia patients. 
This study investigated the prevalence of OCD in a Xhosa-
speaking schizophrenia group.
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Obsessive compulsive disorder (OCD) has been reported in
up to 31% of schizophrenia sufferers.   This study evaluated
the presence of OCD in a Xhosa-speaking schizophrenia
group.  Xhosa patients (N = 509, including 100 sibships) with
schizophrenia were recruited from hospital and community
settings.  The patients underwent a structured clinical
interview for the presence of lifetime co-morbid schizo-
phrenia and OCD.  Only 3 patients (0.5%) fulfilled criteria
for OCD.  No concordance for OCD was noted in the sibship
group.  Our findings differ from those in other parts of the
world, and if replicated, might suggest unique protective
environmental or genetic factors for OCD in certain ethnic
groups.
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Five hundred and nine participants with schizophrenia
between the ages of 13 and 84 years completed all study-
related assessments. Participants were recruited from inpatient
and outpatient hospital services and community clinics
throughout the Western and Eastern Cape provinces of South
Africa. 
Local mental health care workers familiar with the inclusion
and exclusion criteria referred potentially suitable subjects for
screening.  Participants represented the full range of clinical
syndromes seen in schizophrenia and demonstrated a range of
behaviour with regard to adherence to medication regimens.13 15 16
Fully informed, written consent was obtained from participants
and where necessary from a caregiver.  
The study was conducted with the written approval of the
ethics committee of Stellenbosch University and complied with
the ethical guidelines for research involving human
participants as set out in the Declaration of Helsinki
(Edinburgh, 2000). 
Patient inclusion criteria 
Our sample included male and female participants: (i) known
to have schizophrenia;8 (ii) who had maternal and paternal
grandparents of Xhosa origin; and (iii) who had at least one
living parent and one living sibling or alternatively two living
parents, to complete the triad.
Patient assessment 
After giving informed consent, each proband was interviewed
by a psychiatrist (DN) or an experienced, trained research
sister (IM) who administered the standardised Diagnostic
Interview for Genetic Studies (DIGS)17 version 2 in Xhosa, the
native tongue of all participants. The DIGS is a validated
clinical assessment tool designed for diagnosing psychotic
spectrum disorders and includes assessment for the lifetime
presence of OCD. In all cases the clinical interview using the
DIGS provided the primary diagnostic information. Additional
information relating to family history and treatment record was
sought from hospital chart records and information gathered
from family members. Relevant demographic data, medical
history, treatment history and pedigree information were
collected from the proband and his or her family.
Patients were recruited over a 3-year period.  All subjects
were assessed simultaneously by both raters during the first
year of the study, and thereafter regular calibration meetings
were held. 
Data analysis
The demographic parameters and prevalence of OCD in this
sample were calculated using SPSS 10.0 for Windows.
Results
Demographics
Our sample comprised a non-sibship group (N = 301) and 100
sibships (N = 208) divided into 95 pairs, 2 trios and 3 fours.
The mean age of the sample (predominantly male (77%)) was
36.4 (± 10.07) years at interview, with duration of illness being
13.25 (± 8.8) years.  The mean age of onset of schizophrenia
was 22.86 (± 6) years, and 4.4% of the participants were in the
first year of their illness. Twenty-two per cent of the sibships
were recruited from the greater Cape Town area, 14.8% from
Port Elizabeth and East London, while the majority of patients
were from rural Western, Southern and Eastern Cape areas. 
The participants presented with a range of symptomatology
as indicated by the global scores on the Schedule for the
Assessment of Positive Symptoms (SAPS) and the Schedule for
the Assessment of Negative Symptoms (SANS).18 Twenty-eight
per cent had a positive score (mild to severe) on the
hallucinations items, while 40% suffered delusions, 34%
thought disorder, 27% behavioural changes and 70% affective
changes. The total score (global items) of the SANS ranged
from 0 to 24, with a mean of 10.21 (standard deviation (SD)
4.88), and the SAPS total score (global items) ranged from 0 to
20 with a mean of 4.25 (SD 4.82).  Only 3 patients (none part of
a sibship) in this group fulfilled criteria for lifetime OCD on the
relevant section of the DIGS, therefore representing a total
lifetime prevalence of only 0.5% in this sample.
Discussion
The prevalence of co-morbid OCD in this Xhosa-speaking
schizophrenia group was surprisingly low at 0.5%. In addition,
no concordance was noted in the sibships. Previously reported
prevalence rates have tended to vary depending on patient and
disease characteristics. A recent study of hospitalised patients
with chronic schizophrenia found a 23.5% prevalence of OCD,
while a 3.8% prevalence of OCD was documented in patients
with first-admission psychosis.7 On the other hand, Craig et al.19
reported only a lifetime prevalence rate of 7.8% OCD.
Importantly, however, our finding contrasts starkly with most
OCD co-morbidity data in schizophrenia populations of
Caucasian ethnicity, 3 6 10 20 and therefore seemingly raises
interesting questions about this phenomenon in non-Caucasian
groups and black Africans in particular. 
In addition to the low rate of co-morbid OCD in
schizophrenia patients reported by Koen et al.,15 Carey et al.
(personal communication) found a similarly low prevalence
rate for OCD (0.5%) in a randomised general community clinic
setting (sample of Xhosa origin). The Carey study utilised the
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translated and previously used Xhosa version of the MINI
neuropsychiatric interview,21 administered by experienced
Xhosa native language speakers. Importantly, the prevalence
rates for other diagnostic categories in this study, including
anxiety disorders and psychosis, were in line with similar
samples in the developing world.22 Furthermore, a large
ongoing South African study on the genetics of OCD has only
included 1 black patient  (Christine Lochner — personal
communication).
With regard to our study population, it is of particular note
that no participants were using any of the newer atypical
antipsychotic medications, therefore lessening the possibility of
treatment-induced obsessive-compulsive (OC) behaviour.23
Furthermore, instruments with established reliability and
validity were used and in an effort to make our sample more
representative of the schizophrenia population at large,
patients from both hospital and community settings were
included. 
However, our results are subject to a number of limitations.
Firstly, the use of the DIGS as our structured clinical interview
meant that results could only reflect lifetime full syndromal
OCD.  Therefore assessment of OC symptom presence and
severity in the study group was not possible.  Secondly, the
diagnosis of OCD was based on a single cross-sectional inter-
view which may have resulted in important historical
information being lost. It is believed that symptom dimensions
of OCD and schizophrenia have different patterns of exacer-
bation and remission during the course of the illness.1 Craig et
al.19 recently demonstrated that only 33% of patients with
schizophrenia/schizoaffective disorder diagnosed with OC
symptoms still had symptoms 24 months later. Thirdly,
assessment instruments were orally translated into Xhosa.
While every attempt was made to ensure equivalence, cross-
cultural adaptation of instruments may have been preferable. 
While the focus of this study was the determination of
prevalence in order to subtype the sample for future genetic
studies, further work is needed to delineate OCD symptom
profiles in patients with schizophrenia across different ethnic
populations.  Certainly, cross-national comparative studies
suggest that cultural factors may affect the symptom
expression of OCD, although the reasons for the wide variation
in prevalence are not known.  If these data are replicated, it
may support the hypothesis that cultural or genetic factors play
a role in protecting against co-morbid OCD in patients with
schizophrenia of Xhosa descent or mixed race. However,
further work is needed to develop more culturally sensitive
instruments to screen and diagnose OCD in patients with
schizophrenia and other psychotic disorders. While it is
recognised that specific biological mechanisms, including
genetic and auto-immune mechanisms, may play a role in the
pathogenesis of OCD, ethnic variations in these underlying
factors are likely protective factors in certain groups. Further
comparative studies to delineate these putative factors are
warranted.  
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